Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04625257
What this trial is testing

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

Who this might be right for
Coronavirus Infectious Disease 2019 (COVID-19)
University Hospital, Basel, Switzerland 1,600
Not applicableUnknownNCT05787431
What this trial is testing

Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Emmanouil D. Zacharakis 2,000
Not applicableUnknownNCT05534074
What this trial is testing

University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

Who this might be right for
COVID-19 (Coronavirus Disease 2019)COVID-19 PandemicCOVID-19 Pneumonia+5 more
University Hospital, Ioannina 2,500
Not applicableWithdrawnNCT04418531
What this trial is testing

Convalescent Antibodies Infusion in COVID 19 Patients

Who this might be right for
Pneumonia, ViralCorona Virus Infection
Piero Luigi Ruggenenti
Large-scale testing (Phase 3)Ended earlyNCT04425629
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 10,078
Post-approval studies (Phase 4)Study completedNCT05305651
What this trial is testing

Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 217
Not applicableUnknownNCT04359927
What this trial is testing

Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry

Who this might be right for
Sars-CoV2Covid19Cardiovascular Diseases+1 more
Hospital Clinic of Barcelona 4,538
Not applicableStudy completedNCT04416919
What this trial is testing

Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

Who this might be right for
Coronavirus InfectionDisease Prevention
University of Oklahoma 20
Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Not applicableStudy completedNCT04964024
What this trial is testing

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

Who this might be right for
COVID-19 Infection
Central Hospital, Nancy, France 1,293
Early research (Phase 1)Study completedNCT05263921
What this trial is testing

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Bioavailability
Pfizer 12
Not applicableUnknownNCT05568693
What this trial is testing

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Who this might be right for
Corona Virus Disease 2019(COVID-19)
Yu Qin 800
Large-scale testing (Phase 3)Study completedNCT05752201
What this trial is testing

ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno 2,014
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07089719
What this trial is testing

Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)

Who this might be right for
Dyspnea Caused by 2019-nCoV
Assistance Publique - Hôpitaux de Paris 21
Testing effectiveness (Phase 2)WithdrawnNCT04325672
What this trial is testing

Convalescent Plasma to Limit Coronavirus Associated Complications

Who this might be right for
Coronavirus
Mayo Clinic
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Large-scale testing (Phase 3)Study completedNCT04542694
What this trial is testing

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Promomed, LLC 200
Early research (Phase 1)Study completedNCT04283461
What this trial is testing

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

Who this might be right for
COVID-19COVID-19 Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Not applicableStudy completedNCT04394169
What this trial is testing

Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.

Who this might be right for
Post ICU SyndromeChronic PainCovid-19
Hospital Clinic of Barcelona 102
Next Page